Fetal Bovine Serum Market Overview, by Product Type, by Application, by End User-Forecast.
The global fetal bovine serum market Size was valued at USD 0.9 billion in 2022 and is projected to grow from USD 0.95 Billion in 2023 to USD 1.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.60% during the forecast period (2023 - 2030).
Also, fetal bovine serum (FBS) is also considered to be the most widely used in the growth of cell culture media owing to its high content of embryonic procedures. These abilities of fetal bovine serum are driving to the growth of global Fetal Bovine Serum Market Size. Thus, when it is used at appropriate concentrations, it tends to supply many defined and undefined components that satisfy specific metabolic requirements for the culture of cells.
Increase in academic research institutes globally is driving the demand for fetal bovine serum. There have been various governments bodies who are collaborating with academic research institutes to support research activities in pharmaceutical, biotechnology, diagnostics, and veterinary industries as the fetal bovine serum is an essential element for the development of drug and having wide applications in cell-based pharmaceutical research.
Market Segmentation
According to the reports published by Market Research Future Reports has mentioned that the global fetal bovine serum market Research report has been segmented by product type, application, and end user.
Wherein, the fetal bovine serum market Trends, by product type is segmented into charcoal stripped, chromatographic, Dialyzed Fetal Bovine Serum (FBS), exosome depleted, stem cell, and others. Added to this, the stem cell is further segmented into embryonic stem cells qualified, and mesenchymal stem cell qualified.
By the mode of application, the market has been segmented into drug discovery, cell culture media, in-vitro fertilization, human & animal vaccine production, diagnostics, and others.
By the mode of end user, the market is segmented into research & academic institutes, pharmaceutical, biotechnology, and others.
Regional Analysis
Region wise, the global fetal bovine serum market Report has covered the main regions such as Americas, Europe, Asia-Pacific, and the Middle East and Africa.
It has been observed that North America leads the global fetal bovine serum market owing to the growth of the market in rapid pace attributing to the factors such as an increase in funding events for research, and growing awareness about the high-end fetal bovine serum among medical professionals.
Whereas, Europe currently owes a considerable amount of market share in the market. It is observed that, in the near future, the region will predict with exhibiting declination in growth due to emerging ethical issues and religious sentiments about animal-derived products. Such a situation would result in a low market share over the forecast period.
Asia-Pacific is also projected to be the fastest growing region for the market owing to the infrastructural development and increase in outsourcing of research activities to the contract research organizations (CROs) at relatively low cost.
On the other hand, the Middle East and Africa grasp the least share in the market owing to the presence of economically diverse countries, and scarcer initiatives from the government.
Key Players
Fetal Bovine Serum Market Players are as follows, HiMedia Laboratories, Merck KGaA, Bovogen Biologicals Pty Ltd, Atlanta Biologicals Inc., TCS Biosciences Ltd, Tissue Culture Biologicals, Rocky Mountain Biologicals, GE Healthcare, Thermo Fisher Scientific, Bio-Techne, PAN-Biotech, Access Biologicals, Animal Technologies Inc., Nucleus Biologics, Biological Industries, Corning Incorporated,
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.